New from Institute for Clinical and Economic Review (ICER) and Verdant Research: We revisited our 2021 white paper on FDA's accelerated approval pathway.
icer.org/news-insight...
New paper, developed with input from diverse stakeholders, outlines policy options to strengthen the FDA pathway.